A Systematic Review and Meta-Analysis of Randomized Controlled Trials in Use of GLP-1 Receptor Agonist in Type 1 Diabetes Mellitus

被引：0
|
作者：
Panta, Raju
Kunwar, Sumit
Batra, Manav
Ghimire, Dipesh K. C.
Mudgal, Mayuri
Makdissi, Antoine
Chaudhuri, Ajay
Dandona, Paresh
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1156-P
引用
收藏
页码：A308 / A308
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of the dual GIP and GLP-1 receptor agonist tirzepatide for weight loss: a meta-analysis of randomized controlled trials
    de Mesquita, Yasmin Luz Lima
    Calvi, Izabela Pera
    Marques, Isabela Reis
    Cruz, Sara Almeida
    Padrao, Eduardo Messias Hirano
    Carvalho, Pedro Emanuel de Paula
    da Silva, Caroliny Hellen Azevedo
    Cardoso, Rhanderson
    Moura, Filipe Azevedo
    Rafalskiy, Vladimir Vitalievich
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2023, 47 (10) : 883 - 892
  • [22] Treatment with GLP1 receptor agonists reduce serum CRP concentrations in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials
    Mazidi, Mohsen
    Karimi, Ehsan
    Rezaie, Peyman
    Ferns, Gordon A.
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (07) : 1237 - 1242
  • [23] Acupuncture for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials
    Chen, Chao
    Liu, Jia
    Sun, Mengxiao
    Liu, Weihong
    Han, Juan
    Wang, Hongcai
    [J]. COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE, 2019, 36 : 100 - 112
  • [24] Silymarin in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Voroneanu, Luminita
    Nistor, Ionut
    Dumea, Raluca
    Apetrii, Mugurel
    Covic, Adrian
    [J]. JOURNAL OF DIABETES RESEARCH, 2016, 2016
  • [25] The relationship between the use of GLP-1 receptor agonists and the incidence of respiratory illness: a meta-analysis of randomized controlled trials
    Yu, Meixin
    Wang, Ruxin
    Pei, Ling
    Zhang, Xiaofang
    Wei, Jinjing
    Wen, Yun
    Liu, Han
    Ye, Haowen
    Wang, Jinghao
    Wang, Lihong
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2023, 15 (01):
  • [26] Effect of GLP-1 receptor agonists on microvascular endpoints in type 2 diabetes: a systematic review and meta-analysis
    Avgerinos, I.
    Karagiannis, T.
    Malandris, K.
    Liakos, A.
    Mainou, M.
    Andreadis, P.
    Bekiari, E.
    Matthews, D. R.
    Tsapas, A.
    [J]. DIABETOLOGIA, 2018, 61 : S354 - S354
  • [27] Adjunct GLP-1 receptor agonist use in patients with Type 1 Diabetes
    Harkin, P.
    Crowley, R.
    McKenna, M.
    Canavan, R.
    Callanan, I
    Connolly, M.
    O'Shea, D.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2018, 187 : S205 - S205
  • [28] The relationship between the use of GLP-1 receptor agonists and the incidence of respiratory illness: a meta-analysis of randomized controlled trials
    Meixin Yu
    Ruxin Wang
    Ling Pei
    Xiaofang Zhang
    Jinjing Wei
    Yun Wen
    Han Liu
    Haowen Ye
    Jinghao Wang
    Lihong Wang
    [J]. Diabetology & Metabolic Syndrome, 15
  • [29] Cardiovascular outcomes with SGLT-2 inhibitors and GLP-1 receptor agonist in Asians with type 2 diabetes: A systematic review and meta-analysis of cardiovascular outcome trials
    Singh, Awadhesh Kumar
    Singh, Ritu
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (04) : 715 - 722
  • [30] Glucometabolic outcomes of GLP-1 receptor agonist-based therapies in patients with type 2 diabetes: a systematic review and network meta-analysis
    Caruso, Irene
    Di Gioia, Ludovico
    Di Molfetta, Sergio
    Cignarelli, Angelo
    Palmer, Suetonia Cressida
    Natale, Patrizi
    Strippoli, Giovanni F. M.
    Perrini, Sebastio
    Natalicchio, Annalisa
    Laviola, Luigi
    Giorgino, Francesco
    [J]. ECLINICALMEDICINE, 2023, 64
12345